Point Out Statins' CV Benefits STILL Outweigh Diabetes Risk
September 2014
You'll hear more about higher doses of statins increasing diabetes risk...partly due to reports of lawsuits in the lay press.
Help put this into perspective for patients.
Explain that statins' CV benefits STILL outweigh diabetes risk.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote